Authors: Nuruzzaman, Hasan Shahriar Md.1; Bhuiyan, A K M Minhaj Uddin1; Islam, Md. Johirul1; Ullah, Md. Zaker2
Institution: 1. National Institute of Cancer Research and Hospital, Dhaka ; 2. Barts Health NHS Trust, London ;
Oncoplastic breast surgery (OPS) is the preferred approach of treatment for many breast cancer pa ents withcomparable surgical, oncological and survival outcomes. OPS has a huge poten al in Bangladesh, but no study has been conducted till date to quantify the surgical, oncological, cosmetic, and quality of life (QoL) outcomes of OPS.
Methodology: This was a prospective study conducted among 48 consecutive patients with breast cancer at National Institute of Cancer Research & Hospital, Dhaka, who met the inclusion criteria for OPS from March 2021 to June 2022. Multiple socio-demographic, tumour, surgical outcome, cosmesis and QoL related data were collected and analysed using SPSS.
Result: Most patients had T2 and N1 disease (79.2%), with a median age of 40 years. The mean pathological tumour size was 20.38 (±11.54 mm). 15% of patients had post-operative complications. Most of them had a good to excellent cosmesis with a median score of 13. 62.5% were highly satisfied with their body image. Post-operative complication was associated with body image (X^2= 4.227 (df=1); p = 0.039). Cosmesis had significant association with pre-operative T stage (X^2 = 4.785 (df=1); p = 0.028) and post-operative complications (X^2=5.296 (df=1); p = 0.021).
Conclusion: The study results suggest that OPS could be a feasible approach for Bangladeshi patients with a comparable surgical outcome, acceptable complication rate, excellent cosmesis and satisfactory quality of life, in short term, even in a resource-poor se ng. Though, further randomised, multi centre studies with larger sample sizes and comparison groups are required to validate these findings.